Prognosis and outcome of patients with stage IA endometrial carcinoma with and without adjuvant radiotherapy : a 5-year retrospective cohort study

Publication Date

2022

Document Type

Research

Abstract

This study is retrospective cohort analytic study of patients with Stage IA endometrial carcinoma from January 2015 to December 2019. A total of 89 patients were included in this study. Out of these, 23 patients underwent adjuvant radiotherapy after diagnosis and 66 did not underwent radiotherapy. The mean age for patients in bot groups was 53 years old. The mean BMI for patients who underwent adjuvant radiotherapy and those who did not was 23.04 and 22.39 respectively. Among the prognostic factors included in this study, a higher tumor grade, tumor size of more than 2 centimeters, and tumor location showed a significant effect on the disease-free survival rate of patients who underwent adjuvant radiotherapy. But overall, there was no significant difference between the overall survival rate of patients who underwent radiotherapy after diagnosis and those who did not. Anemia and leukopenia were the complications seen in patients who underwent radiotherapy.

This document is currently not available here.

Share

COinS